134 related articles for article (PubMed ID: 11780565)
1. Kallikrein-kinin system activation and its interactions with other plasma haemostatic components in the coronary artery disease.
Czokało-Plichta M; Skibinska E; Kosiorek P; Musiał WJ
Rocz Akad Med Bialymst; 2001; 46():209-24. PubMed ID: 11780565
[TBL] [Abstract][Full Text] [Related]
2. Influence of ACE inhibition on myocardial damage, the Kallikrein-Kinin system and hemostasis during cardiopulmonary bypass surgery.
Walter T; Helber U; Bail D; Heller W; Hoffmeister HM
Thorac Cardiovasc Surg; 2002 Jun; 50(3):150-4. PubMed ID: 12077687
[TBL] [Abstract][Full Text] [Related]
3. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
Walter T; Szabo S; Kazmaier S; Suselbeck T; Borggrefe M; Hoffmeister HM
Thorac Cardiovasc Surg; 2009 Sep; 57(6):368-71. PubMed ID: 19707983
[TBL] [Abstract][Full Text] [Related]
4. Kallikrein-kinin system in patients with neoplastic diseases.
Czokało M; Pałka M; Kralisz P; Filipkowski T
Rocz Akad Med Bialymst; 1996; 41(2):417-28. PubMed ID: 9020555
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
6. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
Nowakowska A
Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
[TBL] [Abstract][Full Text] [Related]
7. Plasma contact activation: a revised hypothesis.
Schmaier AH
Biol Res; 1998; 31(3):251-62. PubMed ID: 9830513
[TBL] [Abstract][Full Text] [Related]
8. [Markers of hemostatic activation in the coronary sinus versus peripheral circulation in coronary artery disease. Effects of percutaneous transluminal coronary angioplasty].
Marín-Blázquez MD; Zuazu-Jausoro I; Rivera J; Sánchez I; Valdés M; Vicente V
Med Clin (Barc); 1998 Nov; 111(15):578-9. PubMed ID: 9859091
[TBL] [Abstract][Full Text] [Related]
9. The kininogen gene family in obstructive uropathy.
El-Dahr SS
Semin Nephrol; 1998 Nov; 18(6):633-40. PubMed ID: 9819154
[TBL] [Abstract][Full Text] [Related]
10. Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease.
Brugts JJ; Isaacs A; Boersma E; van Duijn CM; Uitterlinden AG; Remme W; Bertrand M; Ninomiya T; Ceconi C; Chalmers J; MacMahon S; Fox K; Ferrari R; Witteman JC; Danser AH; Simoons ML; de Maat MP
Eur Heart J; 2010 Aug; 31(15):1854-64. PubMed ID: 20538738
[TBL] [Abstract][Full Text] [Related]
11. [Kallikrein-kinin system: novel facts and concepts (literature review)].
Iarovaia GA
Vopr Med Khim; 2001; 47(1):20-42. PubMed ID: 11385996
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypass.
Pretorius M; McFarlane JA; Vaughan DE; Brown NJ; Murphey LJ
Clin Pharmacol Ther; 2004 Oct; 76(4):379-87. PubMed ID: 15470338
[TBL] [Abstract][Full Text] [Related]
13. Changes in the plasma kinin system in patients with myocardial infarction.
Kolber-Postepska B
Cor Vasa; 1975; 17(3):169-76. PubMed ID: 1204357
[TBL] [Abstract][Full Text] [Related]
14. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
[TBL] [Abstract][Full Text] [Related]
15. Endothelial function and baroreflex sensitivity according to the oral glucose tolerance test in patients with coronary artery disease and normal fasting glucose levels.
Wykretowicz A; Guzik P; Bartkowiak G; Krauze T; Kasinowski R; Dziarmaga M; Wesseling KH; Wysocki H
Clin Sci (Lond); 2005 Oct; 109(4):397-403. PubMed ID: 15948715
[TBL] [Abstract][Full Text] [Related]
16. New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration.
Westermann D; Schultheiss HP; Tschöpe C
Int Immunopharmacol; 2008 Feb; 8(2):148-54. PubMed ID: 18182218
[TBL] [Abstract][Full Text] [Related]
17. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
Speidl WS; Nikfardjam M; Niessner A; Zeiner A; Jordanova N; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
Thromb Res; 2007; 119(3):331-6. PubMed ID: 16616324
[TBL] [Abstract][Full Text] [Related]
18. Biomarker analysis by fluorokine multianalyte profiling distinguishes patients requiring intervention from patients with long-term quiescent coronary artery disease: a potential approach to identify atherosclerotic disease progression.
Gurbel PA; Kreutz RP; Bliden KP; DiChiara J; Tantry US
Am Heart J; 2008 Jan; 155(1):56-61. PubMed ID: 18082490
[TBL] [Abstract][Full Text] [Related]
19. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
20. [Various indicators of hemostasis, plasminogen-plasmin and kinin systems of the blood and their inhibitors in patients with stable angina pectoris and post-infarction cardiosclerosis after graded physical load].
Vinnikova MG; Makarevich IaA
Kardiologiia; 1987 Jul; 27(7):56-9. PubMed ID: 2958650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
